Collagenase Clostridium histolyticum for Peyronie's disease: a contemporary atlas of complications and their management

Collagenase Clostridium histolyticum (CCH) remains the only Food and Drug Administration-approved medical treatment for Peyronie's disease (PD). The initial IMPRESS I and II trials (Investigation for Maximal Peyronie's Reduction Efficacy and Safety), which led to Food and Drug Administrati...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Sexual medicine reviews 2024-06, Vol.12 (3), p.491-496
Hauptverfasser:	Furtado, Thiago P, Osadchiy, Vadim, Andino, Juan J, Eleswarapu, Sriram V, Mills, Jesse N
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!